In a filing, Kiniksa Pharmaceuticals International Plc revealed its Director Malley Thomas acquired Company’s shares for reported $1.6 million on Aug 12 ’25. In the deal valued at $32.40 per share,49,407 shares were bought.
Then, Paolini John F. sold 29,325 shares, generating $954,529 in total proceeds. Upon selling the shares at $32.55, the CHIEF MEDICAL OFFICER now owns 57,403 shares.
Before that, Tessari Eben sold 138,614 shares. Kiniksa Pharmaceuticals International Plc shares valued at $4,602,370 were divested by the CHIEF OPERATING OFFICER at a price of $33.20 per share. As a result of the transaction, Tessari Eben now holds 49,915 shares, worth roughly $1.64 million.
Citigroup initiated its Kiniksa Pharmaceuticals International Plc [KNSA] rating to a Buy in a research note published on March 13, 2025; the price target was $40. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. Wells Fargo began covering KNSA with “an Overweight” recommendation on May 03, 2024. BofA Securities maintained its rating on June 29, 2020. It rated KNSA as “a Buy”.
Price Performance Review of KNSA
On Tuesday, Kiniksa Pharmaceuticals International Plc [NASDAQ:KNSA] saw its stock jump 0.12% to $32.78. Over the last five days, the stock has lost -0.88%. Kiniksa Pharmaceuticals International Plc shares have risen nearly 32.34% since the year began. Nevertheless, the stocks have risen 65.72% over the past one year. While a 52-week high of $33.98 was reached on 08/05/25, a 52-week low of $17.82 was recorded on 01/13/25.
Levels Of Support And Resistance For KNSA Stock
The 24-hour chart illustrates a support level at 32.23, which if violated will result in even more drops to 31.67. On the upside, there is a resistance level at 33.17. A further resistance level may holdings at 33.55.
How much short interest is there in Kiniksa Pharmaceuticals International Plc?
A steep rise in short interest was recorded in Kiniksa Pharmaceuticals International Plc stocks on 2025-07-31, growing by 0.36 million shares to a total of 2.43 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 2.07 million shares. There was a rise of 14.93%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 01, 2020 when BofA/Merrill began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
